JP2007532523A5 - - Google Patents

Download PDF

Info

Publication number
JP2007532523A5
JP2007532523A5 JP2007506834A JP2007506834A JP2007532523A5 JP 2007532523 A5 JP2007532523 A5 JP 2007532523A5 JP 2007506834 A JP2007506834 A JP 2007506834A JP 2007506834 A JP2007506834 A JP 2007506834A JP 2007532523 A5 JP2007532523 A5 JP 2007532523A5
Authority
JP
Japan
Prior art keywords
tetrahydro
oxy
alkyl
cyclopropylmethyl
benzacepin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007506834A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007532523A (ja
Filing date
Publication date
Priority claimed from GBGB0408083.4A external-priority patent/GB0408083D0/en
Application filed filed Critical
Publication of JP2007532523A publication Critical patent/JP2007532523A/ja
Publication of JP2007532523A5 publication Critical patent/JP2007532523A5/ja
Pending legal-status Critical Current

Links

JP2007506834A 2004-04-08 2005-04-06 ヒスタミンh3受容体リガンドとしてのテトラヒドロベンズアゼピン Pending JP2007532523A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0408083.4A GB0408083D0 (en) 2004-04-08 2004-04-08 Novel compounds
PCT/GB2005/001333 WO2005097778A1 (en) 2004-04-08 2005-04-06 Tetrahydrobenzazepines as histamine h3 receptor ligands

Publications (2)

Publication Number Publication Date
JP2007532523A JP2007532523A (ja) 2007-11-15
JP2007532523A5 true JP2007532523A5 (cg-RX-API-DMAC7.html) 2008-05-29

Family

ID=32320647

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007506834A Pending JP2007532523A (ja) 2004-04-08 2005-04-06 ヒスタミンh3受容体リガンドとしてのテトラヒドロベンズアゼピン

Country Status (5)

Country Link
US (1) US20080009479A1 (cg-RX-API-DMAC7.html)
EP (1) EP1735299A1 (cg-RX-API-DMAC7.html)
JP (1) JP2007532523A (cg-RX-API-DMAC7.html)
GB (1) GB0408083D0 (cg-RX-API-DMAC7.html)
WO (1) WO2005097778A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1572215E (pt) 2002-12-20 2009-12-09 Glaxo Group Ltd Derivados de benzo[d]azepina para o tratamento de perturbações neurológicas
GB0513886D0 (en) 2005-07-06 2005-08-10 Glaxo Group Ltd Novel compounds
EP1790646A1 (fr) * 2005-11-24 2007-05-30 Sanofi-Aventis Derives de Isoquinoline et Benzo[h]Isoquinoline, leur preparation et leur utilisation en thérapeutique en tant qu'antagonistes du recepteur de l'histamine H3.
WO2007149728A2 (en) * 2006-06-20 2007-12-27 Alcon Research, Ltd. Aryl and heteroaryl tetrahydrobenzazepine derivatives and their use for treating glaucoma
CN101855211B (zh) 2007-11-13 2013-06-12 大正制药株式会社 苯基吡唑衍生物
TW201039822A (en) 2009-02-06 2010-11-16 Taisho Pharmaceutical Co Ltd Dihydroquinolinone derivatives
BR112014013461A2 (pt) 2011-12-08 2017-06-13 Taisho Pharmaceutical Co Ltd derivado de fenilpirrol
WO2013100054A1 (ja) 2011-12-27 2013-07-04 大正製薬株式会社 フェニルトリアゾール誘導体
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
EP2647377A1 (en) 2012-04-06 2013-10-09 Sanofi Use of an h3 receptor antagonist for the treatment of alzheimer's disease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4210749A (en) * 1974-11-12 1980-07-01 Pennwalt Corporation Substituted 1,2,4,5-tetrahydro-3H,3 benzazepines
JPH07509694A (ja) * 1992-05-14 1995-10-26 ベイラー・カレッジ・オブ・メディシン 突然変異したステロイドホルモン受容体,その使用方法および遺伝子治療のための分子スイッチ
US5364791A (en) * 1992-05-14 1994-11-15 Elisabetta Vegeto Progesterone receptor having C. terminal hormone binding domain truncations
AU2003256793A1 (en) * 2002-08-20 2004-03-11 Eli Lilly And Company Substituted azepines as histamine h3 receptor antagonists, preparation and therapeutic uses
PT2208727E (pt) * 2002-09-19 2012-10-11 Lilly Co Eli Éteres diarílicos como antagonista do receptor opióide
GB0224083D0 (en) * 2002-10-16 2002-11-27 Glaxo Group Ltd Novel compounds
PT1572215E (pt) * 2002-12-20 2009-12-09 Glaxo Group Ltd Derivados de benzo[d]azepina para o tratamento de perturbações neurológicas
WO2005014479A2 (en) * 2003-08-08 2005-02-17 Glaxo Group Limited Process for preparing radiolabeled compounds
RU2006117366A (ru) * 2003-10-23 2007-12-10 Ф.Хоффманн-Ля Рош Аг (Ch) Производные бензазепина в качестве ингибиторов мао-в

Similar Documents

Publication Publication Date Title
AU2017258834B2 (en) Multisubstituted aromatic compounds as serine protease inhibitors
CA2760741C (en) 1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
TWI699359B (zh) 4h-吡咯[3,2-c]吡啶-4-酮衍生物
KR101931468B1 (ko) 아릴메톡시 이소인돌린 유도체 및 그를 포함하는 조성물 및 그의 사용 방법
CN103282360B (zh) Cxcr4受体拮抗剂
EP2518066B1 (en) Novel anti-platelet agent
JPWO2024019103A5 (cg-RX-API-DMAC7.html)
JP5638515B2 (ja) ピロール化合物
RU2012136643A (ru) [5,6]- гетероциклическое соединение
RU2001122111A (ru) Ароматические гетероциклические соединения в качестве противовоспалительных агентов
MX2011000757A (es) Composicion farmaceutica.
JP2013539777A5 (cg-RX-API-DMAC7.html)
JP2006522771A5 (cg-RX-API-DMAC7.html)
JP2011527665A5 (cg-RX-API-DMAC7.html)
US12534469B2 (en) Multi-cyclic IRAK and FLT3 inhibiting compounds and uses thereof
JP2007528887A5 (cg-RX-API-DMAC7.html)
WO2013049591A2 (en) Dual inhibitor compounds and methods of use thereof
RU2009138219A (ru) Новые бензамидные производные и способ их получения
US9745282B2 (en) Indoline compounds as aldosterone synthase inhibitors
JP2006528147A5 (cg-RX-API-DMAC7.html)
JP2008517042A5 (cg-RX-API-DMAC7.html)
KR20160096612A (ko) 5-하이드록시-4-(트리플루오로메틸)피라졸로피리딘 유도체
JP2007506703A5 (cg-RX-API-DMAC7.html)
PL184489B1 (pl) Nowa N acylo podstawiona benzimidazolilo lub imidazopirydynylo podstawiona piperydyna kompozycja farmaceutyczna sposób wytwarzania kompozycji farmaceutycznej i sposób wytwarzania N acylo podstawionej benzimidazolilo lub imidazopiperydynylo podstawionej piperydyny
JP2023550902A5 (cg-RX-API-DMAC7.html)